Intended Audience
This activity will be useful for plastic surgeons, dermatologists, and other aesthetic medicine specialists and physicians who perform facial rejuvenation using autologous fat and stimulatory fillers.
Introduction
Physicians who perform aesthetic rejuvenation are faced with increasing demand for and performance of non-surgical rejuvenation, the availability of a wider variety of injectable products, and the development of innovative advanced techniques for facial rejuvenation. This symposium will review options for facial volumizing, including autologous fat and stimulatory fillers, their appropriate usage and potential adverse events/complications associated with each product/procedure. Using a mix of didactic presentations and case studies, Dr. Danny Vleggaar, Dr. Rebecca Fitzgerald, and Dr. Jonathan Sykes will review the use of autologous fat and dermal fillers for facial volumizing with an emphasis on advanced techniques to optimize aesthetic outcomes. The faculty will share their clinical expertise and approaches to developing customized treatment plans for facial rejuvenation.
Why Is This Activity Important?
According to the American Society for Aesthetic Plastic Surgery, the overall number of cosmetic procedures has increased 457% since 1997; a significant number of these procedures aim to correct facial changes associated with aging, including volume changes. While autologous fat transplantation has often been used to correct facial volume deficits, clinicians have been able to achieve comparable results using stimulatory fillers. Each product has characteristics that support facial volumizing, however, clinicians must be able to match patients and desired outcomes appropriately with products. The increased demand for non-surgical procedures means that clinicians will be called upon to perform a greater number of procedures and will need to utilize advanced techniques to achieve good aesthetic outcomes for diverse patient populations. Expert consensus is that safety and aesthetic outcomes are improved when clinicians: (a) understand normal facial anatomy and relative changes that occur with aging; (b) know the location, thickness, and properties of tissue layers as well as the location and course of major nerves and arteries; (c) are trained in all aspects of rejuvenation techniques; and (d) are familiar with specific product indications, techniques, potential complications and how to manage them, and postoperative care.
Learning Objectives
At the end of this CME activity, participants should be able to:
- Review facial anatomy and fat compartments to improve site-specific augmentation in facial rejuvenation
- Describe the similarities and differences between fat transfer procedures and stimulatory fillers with respect to facial rejuvenation and global facial volumizing
- Evaluate facial volume loss in a specific patient to identify treatment sites, aesthetic corrections, and the best product option(s) for facial volumizing
- Implement strategies at all stages of treatment that minimize adverse effects
- Utilize injection techniques that minimize the risk of adverse events when restoring volume with stimulatory fillers
Educational Methods
Dr. Danny Vleggaar, Dr. Rebecca Fitzgerald, and Dr. Jonathan Sykes will discuss the use of autologous fat and stimulatory fillers in facial rejuvenation and global facial volumizing with an emphasis on advanced techniques to correct volume changes associated with aging. The program will feature a review of facial anatomy, a summary of available products/procedures, their uses, and potential adverse events/complications associated with each product/procedure, and a discussion of innovative aesthetic strategies and advanced techniques. The faculty will share their clinical expertise and approaches to developing customized treatment plans for facial rejuvenation and global facial volumizing.
Method of Participation
This activity should take approximately one hour to complete. Participants should first read the objectives and other introductory CME information, then proceed to the educational offering. After completing an activity, participants may choose to complete the posttest toward the award of a certificate for credit. This credit is valid through April 30, 2011. No credit will be given after this date.
In the event you are unable to print the certificate, please e-mail editor@dannemiller.com and a certificate will be mailed within 2 weeks.
CME Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Dannemiller Inc. and Athena Education Group. Dannemiller Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation
Dannemiller Inc. designates this educational activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. CME activities approved by the American Medical Association (AMA) are recognized by the European Accreditation Council for Continuing Medical Education (EACCME).
Faculty Biographies
Rebecca Fitzgerald, MD
Dr. Rebecca Fitzgerald is on the clinical faculty at the University of California — Los Angeles (UCLA) and is in private practice in Los Angeles, California.
Dr. Fitzgerald graduated from Louisiana State University Medical School, and subsequently completed an Internal Medicine residency at UCLA/Cedars Sinai Medical Center in Los Angeles, California before returning home to New Orleans, where she completed her training in Dermatology.
Dr. Fitzgerald is a Diplomat of the American Board of Dermatology and a Fellow of both the American Academy of Dermatology (AAD) and the American Society of Dermatologic Surgery (ASDS).
Dr. Fitzgerald is a member of the Botox Cosmetic National Education Faculty as well as a recognized expert in the use of poly-L-lactic acid. Dr. Fitzgerald travels around the world teaching other physicians the advanced injection techniques required for the use of dermal fillers. She has published in peer-reviewed medical journals, presented at medical educational seminars and has been featured as a medical expert on local and national television programs.
Danny Vleggaar, MD
Dr. Danny Vleggaar works in private practice at the Centre Dermato-Cosmetique Roseraie in Geneva, Switzerland. Previously he was a Consultant for cosmetic dermatology at the Nouvelle Clinic Vert Pré, Geneva, Switzerland, the Medical Director of Medi-Line Clinic, Amsterdam and the Clinic for Injectables, The Hague, The Netherlands.
Dr. Vleggaar graduated from Vrije Universiteit, Amsterdam in 1986. He is a registered and board-certified specialist in family medicine, with a specialty in dermatology and allergy.
Dr. Vleggaar has extensive experience in the use of injectable fillers; he began to focus on non-surgical facial rejuvenation in 1992. Dr. Vleggaar is a recognized expert in the use of poly-L-lactic acid (PLLA) and pioneered injection techniques for facial sculpting with PLLA that are now accepted and taught as the standard. He has presented his clinical experiences with dermal fillers and collagen stimulators at numerous international meetings for dermatology, plastic surgery and cosmetic medicine. Dr. Vleggaar has led presentations on facial rejuvenation, lipoatrophy, and injectables at professional meetings and conferences in Europe, Asia, and the United States. Drawing from his extensive clinical experience, he has written several book chapters and numerous publications for peer-reviewed journals.
Jonathan M. Sykes, MD, FACS
Dr. Jonathan Sykes is the Director of the Facial Plastics and Reconstructive Surgery Department at the University of California at Davis Medical Center in Sacramento, California. Dr. Sykes oversees an active medical practice and maintains one of the nation’s most respected fellowship programs for facial plastic surgeons seeking advanced training. He also practices with Roseville Facial Plastic Surgery in Roseville, California.
Dr. Sykes graduated from the George Washington University School of Medicine and Health Sciences in Washington, DC, where he subsequently completed a residency in General Surgery.
Dr. Sykes is the current president-elect of American Academy of Facial Plastic and Reconstructive Surgery, having previously served as the vice president of education. Dr. Sykes is a frequent guest lecturer, giving hundreds of presentations to fellow surgeons on facial plastic surgery procedures. In addition, he has published more than 100 professional articles and co-edited three textbooks. He also designed patented instruments used by surgeons worldwide to simplify the endoscopic brow lift procedure and provide faster patient recovery times.
Disclosures
In accordance with the Accreditation Council for Continuing Medical Education (ACCME), Dannemiller Inc. requires that any person who is in a position to control the content of a CME activity must disclose all relevant financial relationships they have with a commercial interest. Accordingly:
Rebecca Fitzgerald, MD, discloses that she received compensation as a speaker for sanofi-aventis; and as a consultant or advisory board member for sanofi-aventis.
Danny Vleggaar, MD, discloses that he received compensation as a consultant or advisory board member
for sanofi-aventis.
Jonathan Sykes, MD discloses that he received compensation as a speaker for Medicis and sanofi-aventis,
as a consultant or advisory board member for Medicis and sanofi-aventis, and as an investigator for Medicis.
Wendy Gloffke, PhD, medical writer, has no disclosures to report.
Dannemiller Inc. and Athena Education Group staff members who were involved in the development of this activity have no financial relationships with any commercial interests that are relevant to this activity.
To resolve identified conflicts of interest, the educational content was fully peer-reviewed by a physician member of the Dannemiller Inc. Content Review Committee, who has nothing to disclose. The resulting certified activity was found to provide educational content that is current, evidence-based, and commercially balanced.
Unlabeled or Investigational Use Statement
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the US Food and Drug Administration (FDA). The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/participants should critically evaluate the information presented and are encouraged to consult appropriate resources for any product or device mentioned in this program.
Dannemiller Inc., the faculty, Athena Education Group, and sanofi-aventis do not endorse the use of any product outside the FDA-labeled indications. Healthcare professionals should not utilize the procedures, products, or diagnostic techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Dannemiller Inc., sanofi-aventis, or Athena Education Group. This material is prepared based upon a review of multiple sources of information, but is not exhaustive of the subject matter. Therefore, healthcare professionals and other individuals should review and consider other publications and materials on the subject matter and not rely solely upon the information contained within this educational activity.